Kazuma Daiku

Success rate of microsatellite instability examination and complete response with pembrolizumab in biliary tract cancer

Yugo Kai, Kenji Ikezawa, Ryoji Takada et al. · JGH Open · 2021 · 34 citations · Full text

Medicine, Oncology, Pathology +17

The Survival Benefit of Chemoradiotherapy following Induction Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Unresectable Locally Advanced Pancreatic Cancer

Ryoji Takada, Kenji Ikezawa, Kazuma Daiku et al. · Cancers · 2021 · 21 citations · Full text

Medicine, Oncology, Pharmacology +13

Efficacy and safety of modified fluorouracil/leucovorin plus irinotecan and oxaliplatin (mFOLFIRINOX) compared with S‐1 as second‐line chemotherapy in metastatic pancreatic cancer

Kenji Ikezawa, Ryosuke Kiyota, Ryoji Takada et al. · JGH Open · 2021 · 19 citations · Full text

Medicine, Oncology, Pharmacology +13

Chemotherapy effectiveness and age-group analysis of older adult patients with metastatic pancreatic cancer: A Japanese cancer registry cohort study

Kazuma Daiku, Kenji Ikezawa, Toshitaka Morishima et al. · Journal of Geriatric Oncology · 2022 · 14 citations

Medicine, Geriatric Medicine, Oncology +17

Early detection of venous thromboembolism after the initiation of chemotherapy predicts a poor prognosis in patients with unresectable metastatic pancreatic cancer who underwent first-line chemotherapy with gemcitabine plus nab-paclitaxel

Takuo Yamai, Kenji Ikezawa, Erika Hiraga et al. · PLoS ONE · 2022 · 11 citations · Full text

Medicine, Oncology, Pharmacology +16